Literature DB >> 22825211

Antitumour potential of catalytic DNA.

Darren J Burgess.   

Abstract

Year:  2012        PMID: 22825211     DOI: 10.1038/nrc3328

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  DNAzyme targeting c-jun suppresses skin cancer growth.

Authors:  Hong Cai; Fernando S Santiago; Leonel Prado-Lourenco; Bo Wang; Margaret Patrikakis; Miles P Davenport; Ghassan J Maghzal; Roland Stocker; Christopher R Parish; Beng H Chong; Graham J Lieschke; Tak-Wah Wong; Colin N Chesterman; Douglas J Francis; Fergal J Moloney; Ross St C Barnetson; Gary M Halliday; Levon M Khachigian
Journal:  Sci Transl Med       Date:  2012-06-20       Impact factor: 17.956

  1 in total
  2 in total

1.  Spiegelzymes® mirror-image hammerhead ribozymes and mirror-image DNAzymes, an alternative to siRNAs and microRNAs to cleave mRNAs in vivo?

Authors:  Eliza Wyszko; Florian Mueller; Marta Gabryelska; Angelika Bondzio; Mariusz Popenda; Jan Barciszewski; Volker A Erdmann
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

2.  Spiegelzymes: sequence specific hydrolysis of L-RNA with mirror image hammerhead ribozymes and DNAzymes.

Authors:  Eliza Wyszko; Maciej Szymański; Heinz Zeichhardt; Florian Müller; Jan Barciszewski; Volker A Erdmann
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.